ACE and Alzheimer disease: Our previous studies, and findings from others, indicate that cRAS signaling is overactivated in AD and angiotensin-converting enzyme-1 (ACE-1), angiotensin-II (ang-II), and ang-II type 1 receptor (AT1R) levels are elevated (9–12).